Effect of natalizumab on B lymphocytes in patients with multiple sclerosis

被引：0
|
作者：
Putzki, N. [1 ]
Kumar, M. [1 ]
Grosse-Wilde, H. [1 ]
Kreuzfelder, E. [1 ]
机构：
[1] Univ Clin Essen, Essen, Germany
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab
    Leclerc, Mathieu
    Lesesve, Jean-Francois
    Gaillard, Baptiste
    Troussard, Xavier
    Tourbah, Ayman
    Debouverie, Marc
    Daliphard, Sylvie
    Delmer, Alain
    LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 910 - 912
  • [2] Natalizumab treatment alters microRNA expression in B-lymphocytes in multiple sclerosis patients
    Sievers, C.
    Meira, M.
    Hoffmann, F.
    Fontoura, P.
    Kappos, L.
    Lindberg, R. L. P.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S127 - S128
  • [3] The effect of Natalizumab on the retina of patients with Multiple Sclerosis
    Basili, Elisa
    Mauceri, Valentina Annamaria
    Ponzano, Marta
    Bovis, Francesca
    Miscioscia, Alessandro
    Zanotelli, Giovanni
    De Napoli, Federica
    Gaggiola, Marta
    Rinaldi, Francesca
    Perini, Paola
    Gallo, Paolo
    Puthenparampil, Marco
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 989 - 990
  • [4] Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis
    de Almeida Franzoi, Andre Eduardo
    de Moraes Machado, Fernanda Subtil
    Gomes de Medeiros Junior, Washigton Luiz
    Bandeira, Isabelle Pastor
    Brandao, Wesley Nogueira
    Magno Goncalves, Marcus Vinicius
    HELIYON, 2021, 7 (06)
  • [5] Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients
    Zanotti, Cinzia
    Chiarini, Marco
    Serana, Federico
    Sottini, Alessandra
    Garrafa, Emirena
    Torri, Fabio
    Caimi, Luigi
    Rasia, Sarah
    Capra, Ruggero
    Imberti, Luisa
    CLINICAL IMMUNOLOGY, 2012, 145 (01) : 19 - 26
  • [6] Effect of natalizumab therapy on cognitive function in patients with multiple sclerosis
    Jonsdottir, S.
    Hjaltason, H.
    Prainsdottir, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 713 - 713
  • [7] Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients
    Sainz-Amo, Raquel
    Rodero-Romero, Alexander
    Monreal, Enric
    Chico-Garcia, Juan Luis
    Rodriguez-Jorge, Fernando
    Fernandez-Velasco, Jose Ignacio
    Villarrubia, Noelia
    Veiga-Gonzalez, Jose Luis
    de la Maza, Susana Sainz
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar, Luisa Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [8] Use of Natalizumab in Multiple Sclerosis Patients
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2010, 37 (01) : 98 - 104
  • [9] CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes
    Lesesve, J-F
    Debouverie, M.
    Bittencourt, M. Decarvalho
    Bene, M-C
    BONE MARROW TRANSPLANTATION, 2011, 46 (11) : 1489 - 1491
  • [10] CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes
    J-F Lesesve
    M Debouverie
    M Decarvalho Bittencourt
    M-C Béné
    Bone Marrow Transplantation, 2011, 46 : 1489 - 1491
12345